Haleon (HLN) Competitors GBX 347.10 -9.60 (-2.69%) As of 05:11 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock HLN vs. ULVR, SN, SGE, WHR, ANP, CLX, TPX, PNPL, LEG, and HIKShould you be buying Haleon stock or one of its competitors? The main competitors of Haleon include Unilever (ULVR), Smith & Nephew (SN), The Sage Group (SGE), Warehouse REIT (WHR), Anpario (ANP), Calnex Solutions (CLX), TPXimpact (TPX), Pineapple Power (PNPL), Legendary Investments (LEG), and Hikma Pharmaceuticals (HIK). Haleon vs. Its Competitors Unilever Smith & Nephew The Sage Group Warehouse REIT Anpario Calnex Solutions TPXimpact Pineapple Power Legendary Investments Hikma Pharmaceuticals Unilever (LON:ULVR) and Haleon (LON:HLN) are both large-cap consumer goods companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, valuation, profitability, risk and dividends. Does the media refer more to ULVR or HLN? In the previous week, Unilever had 1 more articles in the media than Haleon. MarketBeat recorded 8 mentions for Unilever and 7 mentions for Haleon. Unilever's average media sentiment score of 0.36 beat Haleon's score of 0.25 indicating that Unilever is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Unilever 2 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Haleon 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable valuation and earnings, ULVR or HLN? Unilever has higher revenue and earnings than Haleon. Unilever is trading at a lower price-to-earnings ratio than Haleon, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUnilever£59.77B1.86£7.79B£2.242,029.46Haleon£11.02B2.82£1.07B£0.172,082.04 Which has more risk and volatility, ULVR or HLN? Unilever has a beta of 0.22, meaning that its stock price is 78% less volatile than the S&P 500. Comparatively, Haleon has a beta of 0.19, meaning that its stock price is 81% less volatile than the S&P 500. Is ULVR or HLN a better dividend stock? Unilever pays an annual dividend of GBX 1.79 per share and has a dividend yield of 0.0%. Haleon pays an annual dividend of GBX 0.07 per share and has a dividend yield of 0.0%. Unilever pays out 80.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Haleon pays out 39.5% of its earnings in the form of a dividend. Do institutionals & insiders hold more shares of ULVR or HLN? 45.8% of Unilever shares are held by institutional investors. Comparatively, 25.5% of Haleon shares are held by institutional investors. 1.4% of Unilever shares are held by insiders. Comparatively, 0.0% of Haleon shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is ULVR or HLN more profitable? Unilever has a net margin of 11.01% compared to Haleon's net margin of 9.66%. Unilever's return on equity of 34.57% beat Haleon's return on equity.Company Net Margins Return on Equity Return on Assets Unilever11.01% 34.57% 8.62% Haleon 9.66%6.54%4.45% Do analysts rate ULVR or HLN? Unilever presently has a consensus price target of GBX 4,518, indicating a potential downside of 0.62%. Haleon has a consensus price target of GBX 436.67, indicating a potential upside of 25.59%. Given Haleon's stronger consensus rating and higher probable upside, analysts clearly believe Haleon is more favorable than Unilever.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Unilever 3 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 1.80Haleon 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 SummaryUnilever beats Haleon on 12 of the 17 factors compared between the two stocks. Get Haleon News Delivered to You Automatically Sign up to receive the latest news and ratings for HLN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HLN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HLN vs. The Competition Export to ExcelMetricHaleonDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£31.13B£1.64B£5.80B£2.58BDividend Yield1.87%2.93%5.72%5.30%P/E Ratio2,082.0467.3375.115,423.37Price / Sales2.821,298.97511.7696,681.36Price / Cash21.9510.3725.8127.93Price / Book1.9111.6313.458.98Net Income£1.07B£20.70B£3.29B£5.89B7 Day Performance-3.64%-0.40%0.08%0.69%1 Month Performance-2.44%1.73%4.59%44.83%1 Year Performance-12.05%4.40%75.30%174.12% Haleon Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HLNHaleon2.2045 of 5 starsGBX 347.70-2.5%GBX 436.67+25.6%N/A£31.13B£11.02B2,082.0425,408Gap DownHigh Trading VolumeULVRUnilever1.0669 of 5 starsGBX 4,682-0.3%GBX 4,518-3.5%-7.1%£114.80B£59.77B2,090.18148,000High Trading VolumeSNSmith & Nephew2.945 of 5 starsGBX 1,412.50-0.2%GBX 1,379.33-2.3%+17.5%£15.48B£7.08B50.8618,452High Trading VolumeSGEThe Sage Group2.8481 of 5 starsGBX 1,103.21+1.3%GBX 3,500+217.3%+3.3%£10.54B£2.42B3,208.8711,326Dividend IncreaseWHRWarehouse REITN/AGBX 113flatN/A+26.4%£480.09M£55.58M1,153.0661,000ANPAnpario0.6141 of 5 starsGBX 428+4.4%GBX 435+1.6%+52.6%£72.53M£38.20M1,752.66109Earnings ReportCLXCalnex Solutions2.1226 of 5 starsGBX 58.01+0.0%GBX 115+98.3%N/A£50.98M£18.39M16,112.789,000Positive NewsTPXTPXimpactN/AGBX 17-1.4%N/A-55.9%£15.22M£77.34M-168.3212,000PNPLPineapple PowerN/AN/AN/AN/A£2.28MN/A-274.002High Trading VolumeLEGLegendary InvestmentsN/AN/AN/AN/A£0.00N/A0.0019,900Gap DownHIKHikma Pharmaceuticals3.5945 of 5 starsGBX 1,699flatGBX 2,627.50+54.6%-16.8%£3.76B£3.22B1,017.379,100Negative News Related Companies and Tools Related Companies ULVR Alternatives SN Alternatives SGE Alternatives WHR Alternatives ANP Alternatives CLX Alternatives TPX Alternatives PNPL Alternatives LEG Alternatives HIK Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:HLN) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haleon plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Haleon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.